Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,853.70
+31.40 (1.72%)
At close: Nov 6, 2026
Bharat Parenterals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,948 | 3,454 | 3,404 | 2,612 | 2,180 | 2,120 |
Other Revenue | -9.39 | - | - | 0 | 13.22 | 3.17 |
| 3,939 | 3,454 | 3,404 | 2,612 | 2,193 | 2,123 | |
Revenue Growth | 10.37% | 1.48% | 30.31% | 19.11% | 3.28% | 2.46% |
Cost of Revenue | 2,163 | 1,971 | 2,037 | 1,614 | 1,394 | 1,379 |
Gross Profit | 1,776 | 1,484 | 1,367 | 998.57 | 799.43 | 744.1 |
Selling, General & Admin | 777.61 | 692.8 | 512.14 | 245.37 | 187.63 | 159.33 |
Other Operating Expenses | 673.87 | 632.2 | 808.84 | 480.31 | 354.64 | 273.18 |
Operating Expenses | 1,799 | 1,668 | 1,674 | 815.88 | 601.1 | 499.11 |
Operating Income | -23.32 | -183.81 | -307.36 | 182.69 | 198.33 | 244.99 |
Interest Expense | -102.44 | -114.66 | -119.17 | -31.81 | -21.86 | -9.67 |
Interest & Investment Income | 8.23 | 8.23 | 37.96 | 4.97 | 3.38 | 16.76 |
Currency Exchange Gain (Loss) | 82.87 | 82.87 | 61.9 | 33.3 | 46.99 | 13.89 |
Other Non Operating Income (Expenses) | -10.05 | -10.05 | -2.02 | -1.17 | 6.12 | 13.87 |
EBT Excluding Unusual Items | -44.72 | -217.43 | -328.69 | 187.98 | 232.96 | 279.84 |
Gain (Loss) on Sale of Investments | 0.26 | 0.26 | -2.83 | -0.44 | 3.43 | 11.25 |
Gain (Loss) on Sale of Assets | 1.73 | 1.73 | -9.76 | -0.4 | -0.91 | -7.4 |
Pretax Income | -41.53 | -214.23 | -339.51 | 187.22 | 235.47 | 283.69 |
Income Tax Expense | 54.21 | 58.82 | 97.25 | 82.07 | 78.32 | 70.65 |
Earnings From Continuing Operations | -95.73 | -273.06 | -436.75 | 105.14 | 157.15 | 213.04 |
Minority Interest in Earnings | 108.17 | 191.18 | 310.49 | 40.03 | - | - |
Net Income | 12.44 | -81.88 | -126.26 | 145.17 | 157.15 | 213.04 |
Net Income to Common | 12.44 | -81.88 | -126.26 | 145.17 | 157.15 | 213.04 |
Net Income Growth | - | - | - | -7.62% | -26.24% | 4.49% |
Shares Outstanding (Basic) | 5 | 7 | 7 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 5 | 7 | 7 | 6 | 6 | 6 |
Shares Change | 6.18% | 5.16% | 12.58% | 0.82% | 0.60% | 0.19% |
EPS (Basic) | 2.27 | -11.88 | -19.26 | 24.94 | 27.21 | 37.11 |
EPS (Diluted) | 2.27 | -11.88 | -19.26 | 24.94 | 27.21 | 37.11 |
EPS Growth | - | - | - | -8.37% | -26.67% | 4.29% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -15.71 | -563.3 | -1,090 | -699.37 | -268.38 |
Free Cash Flow Per Share | - | -2.28 | -85.95 | -187.24 | -121.11 | -46.75 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 0.750 | - |
Dividend Growth | - | 0% | 0% | 33.33% | - | - |
Gross Margin | 45.09% | 42.95% | 40.16% | 38.23% | 36.45% | 35.04% |
Operating Margin | -0.59% | -5.32% | -9.03% | 6.99% | 9.04% | 11.54% |
Profit Margin | 0.32% | -2.37% | -3.71% | 5.56% | 7.17% | 10.03% |
Free Cash Flow Margin | - | -0.46% | -16.55% | -41.73% | -31.89% | -12.64% |
EBITDA | 319.51 | 158.7 | 45.86 | 272.89 | 257.15 | 311.6 |
EBITDA Margin | 8.11% | 4.59% | 1.35% | 10.45% | 11.73% | 14.67% |
D&A For EBITDA | 342.83 | 342.51 | 353.22 | 90.21 | 58.82 | 66.61 |
EBIT | -23.32 | -183.81 | -307.36 | 182.69 | 198.33 | 244.99 |
EBIT Margin | -0.59% | -5.32% | -9.03% | 6.99% | 9.04% | 11.54% |
Effective Tax Rate | - | - | - | 43.84% | 33.26% | 24.90% |
Revenue as Reported | 4,034 | 3,550 | 3,520 | 2,659 | 2,297 | 2,198 |
Advertising Expenses | - | 20.01 | 15.51 | 17.5 | 7.67 | 6.23 |